Press release
Gouty Arthritis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody AB, Ventyx
DelveInsight's "Gouty Arthritis Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Gouty Arthritis, historical and forecasted epidemiology as well as the Gouty Arthritis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Gouty Arthritis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Gouty Arthritis Market Forecast [https://www.delveinsight.com/sample-request/gouty-arthritis-gout-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Gouty Arthritis Market Report:
* The Gouty Arthritis market size is estimated to grow at a significant CAGR during the study period (2019-2032)
* In October 2023, Atom Bioscience, a biotechnology firm based in China, has administered the initial dose to the first patient in a Phase IIb/III clinical trial of ABP-671 for the treatment of chronic gout, a prevalent form of inflammatory arthritis. This randomized, multi-center, double-blind study aims to enroll 580 patients from the United States and other countries.
* In October 2023, Selecta Biosciences, Inc. has announced an agreement to transfer the manufacturing and development rights, along with the remaining clinical operations, of ImmTOR for SEL-212 to its partner in development and commercialization, Swedish Orphan Biovitrum AB (publ.) (Sobi). Effective November 6, 2023, Sobi will assume responsibility for manufacturing and commercial supply of ImmTOR for SEL-212. SEL-212, a combination of Selecta's ImmTOR immune tolerance platform and a therapeutic uricase enzyme (pegadricase), is being developed for the treatment of chronic refractory gout.
* Over 1.2 million cases of Gouty Arthritis were reported to be prevalent in the 7MM in 2021, with the United States reporting the largest number of cases.
* There were over 241,000 Gouty Arthritis cases diagnosed in the US in 2021, and over 460,000 cases in the EU-5. During the projected period (2022-2032), there is expected to be an increase in these numbers.
* Gouty Arthritis affected women more than it did men, according to DelveInsight's data. For example, in Japan in 2021, there were about 21,000 cases of Gouty Arthritis in males and about 29,000 in females.
* Key Gouty Arthritis Companies: Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody AB, Ventyx Biosciences, Aclaris Therapeutics, AbbVie, Novartis, Janssen Research & Development, LLC, MoonLake Immunotherapeutics AG, and others
* Key Gouty Arthritis Therapies: ILUMYA, Deucravacitinib, Bimekizumab, Izokibep, SUNPG18_07, VTX958, ATI-450, Risankizumab, Upadacitinib, AIN457, Ustekinumab, Sonelokimab and others
* The Gouty Arthritis epidemiology based on gender analyzed that the prevalence of moderate cases is the highest, followed by severe and mild cases
* The Gouty Arthritis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Gouty Arthritis pipeline products will significantly revolutionize the Gouty Arthritis market dynamics.
Gouty Arthritis Overview
Gouty arthritis, commonly referred to as gout, is a form of inflammatory arthritis caused by the accumulation of urate crystals in the joints. These crystals form when there is an excess of uric acid in the blood, which can occur due to various factors such as genetics, diet, and lifestyle choices. Gout typically affects the big toe, causing intense pain, swelling, redness, and warmth in the affected joint.
Get a Free sample for the Gouty Arthritis Market Report:
https://www.delveinsight.com/report-store/gouty-arthritis-gout-market [https://www.delveinsight.com/report-store/gouty-arthritis-gout-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Gouty Arthritis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Gouty Arthritis Epidemiology Segmentation:
The Gouty Arthritis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
* Total Prevalence of Gouty Arthritis
* Prevalent Cases of Gouty Arthritis by severity
* Gender-specific Prevalence of Gouty Arthritis
* Diagnosed Cases of Episodic and Chronic Gouty Arthritis
Download the report to understand which factors are driving Gouty Arthritis epidemiology trends @ Gouty Arthritis Epidemiology Forecast [https://www.delveinsight.com/sample-request/gouty-arthritis-gout-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Gouty Arthritis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Gouty Arthritis market or expected to get launched during the study period. The analysis covers Gouty Arthritis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Gouty Arthritis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Gouty Arthritis Therapies and Key Companies
* ILUMYA: Sun Pharma
* Deucravacitinib: Bristol-Myers Squibb
* Bimekizumab: UCB Biopharma
* Izokibep: Affibody AB
* SUNPG18_07: Sun Pharmaceutical Industries Limited
* VTX958: Ventyx Biosciences, Inc
* ATI-450: Aclaris Therapeutics, Inc.
* Risankizumab: AbbVie
* Upadacitinib: AbbVie
* AIN457: Novartis
* Ustekinumab: Janssen Research & Development, LLC
* Sonelokimab: MoonLake Immunotherapeutics AG
Discover more about therapies set to grab major Gouty Arthritis market share @ Gouty Arthritis Treatment Market [https://www.delveinsight.com/sample-request/gouty-arthritis-gout-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Gouty Arthritis Market Strengths
* Increased prevalence, growth in awareness, and lifestyle changes have necessitated changes in the diagnosis and treatment of Gouty Arthritis in the recent decade
* Various screening tools, including self-administered questionnaires, have been developed to help dermatologists, rheumatologist, and general physicians to identify patients who might suffer from Gouty Arthritis
Gouty Arthritis Market Unmet Needs
* Lack of biomarkers
* Challenges in current treatment options
* Challenges in current guidelines
* Poor disease understanding
* Challenges in managing comorbidities
Scope of the Gouty Arthritis Market Report
* Study Period: 2019-2032
* Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
* Key Gouty Arthritis Companies: Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody AB, Sun Pharmaceutical Industries, Ventyx Biosciences, Aclaris Therapeutics, AbbVie, Novartis, Janssen Research & Development, LLC, MoonLake Immunotherapeutics AG, and others
* Key Gouty Arthritis Therapies: ILUMYA, Deucravacitinib, Bimekizumab, Izokibep, SUNPG18_07, VTX958, ATI-450, Risankizumab, Upadacitinib, AIN457, Ustekinumab, Sonelokimab, and others
* Gouty Arthritis Therapeutic Assessment: Gouty Arthritis current marketed and Gouty Arthritis emerging therapies
* Gouty Arthritis Market Dynamics: Gouty Arthritis market drivers and Gouty Arthritis market barriers
* Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
* Gouty Arthritis Unmet Needs, KOL's views, Analyst's views, Gouty Arthritis Market Access and Reimbursement
To know more about Gouty Arthritis companies working in the treatment market, visit @ Gouty Arthritis Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/gouty-arthritis-gout-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Gouty Arthritis Market Report Introduction
2. Executive Summary for Gouty Arthritis
3. SWOT analysis of Gouty Arthritis
4. Gouty Arthritis Patient Share (%) Overview at a Glance
5. Gouty Arthritis Market Overview at a Glance
6. Gouty Arthritis Disease Background and Overview
7. Gouty Arthritis Epidemiology and Patient Population
8. Country-Specific Patient Population of Gouty Arthritis
9. Gouty Arthritis Current Treatment and Medical Practices
10. Gouty Arthritis Unmet Needs
11. Gouty Arthritis Emerging Therapies
12. Gouty Arthritis Market Outlook
13. Country-Wise Gouty Arthritis Market Analysis (2019-2032)
14. Gouty Arthritis Market Access and Reimbursement of Therapies
15. Gouty Arthritis Market Drivers
16. Gouty Arthritis Market Barriers
17. Gouty Arthritis Appendix
18. Gouty Arthritis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=gouty-arthritis-market-report-2032-epidemiology-data-pipeline-therapies-latest-fda-ema-pdma-approvals-by-delveinsight-sun-pharma-bristolmyers-squibb-ucb-biopharma-affibody-ab-ventyx]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gouty Arthritis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody AB, Ventyx here
News-ID: 3466189 • Views: …
More Releases from ABNewswire
Central Florida Notary Express, LLC Expands 24/7 Notary and Mobile Notary Servic …
Winter Park, FL - Central Florida Notary Express, LLC, a 24/7 provider of notary and mobile notary services and certified loan signings, announced expanded same-day coverage across the Greater Orlando area, including Orlando, Winter Park, Maitland, Casselberry, Winter Springs, DeLand, DeBary, Deltona, Sanford, and Lake Mary. The company offers on-site and curbside notarization for jurats, acknowledgments, power of attorney (POA), wills, health care surrogate forms, copy certifications, and real-estate loan…
Stafili Wine Cafe Brings the Heart of Greece to New York City - A Sophisticated …
Nestled in the vibrant neighborhoods of West Village and Tribeca, Stafili Wine Cafe is redefining New York's dining scene with an unforgettable Greek-inspired experience that blends exceptional wines, authentic Mediterranean cuisine, and an inviting, intimate atmosphere. Whether you're seeking a cozy date night, an after-work escape, or a refined venue for social gatherings, Stafili promises an indulgent journey through the flavors, aromas, and spirit of Greece - without ever leaving…
Solar Heroes Launches Premium Solar Control Window Film Solutions in Singapore, …
As Singapore continues to face soaring temperatures and rising energy costs, Solar Heroes, a premium solar control window film supplier and installer, is stepping up to deliver an innovative solution for homes, offices, and commercial spaces. With a commitment to sustainability, comfort, and performance, Solar Heroes is revolutionizing how Singaporeans experience indoor living through advanced solar control window film technology. More information can be found at https://solarheroes.sg.
Singapore - As Singapore…
Dlinxoutreach Unlocks the Power of AI Ecosystems for Companies Seeking Higher RO …
In today's fintech-driven digital economy, artificial intelligence is no longer a speculative technology; it is a monetizable growth driver. Global private investment in AI reached $252 billion in 2024, a 44.5% year-over-year increase according to Stanford's AI Index. In financial services, 77% of executives report achieving positive ROI within the first year of AI deployment, according to Bank Automation News. A Boston Consulting Group study further shows that one in…
More Releases for Gout
Chronic Gout Market Trends, Therapeutics, and Growth Opportunities
Chronic gout is a progressive form of arthritis characterized by elevated uric acid levels, leading to severe joint pain, inflammation, and long-term joint damage. This condition affects millions worldwide, often resulting in impaired mobility and reduced quality of life. With rising prevalence due to lifestyle changes, aging populations, and dietary habits, the Chronic Gout market is witnessing a surge in demand for advanced therapeutics, early diagnostics, and patient management solutions.
Download…
Chronic Gout Market Massive Growth opportunity Ahead
Introduction
Chronic gout is a form of arthritis characterized by recurrent attacks of severe pain, swelling, and inflammation in the joints, often due to the accumulation of uric acid crystals. This condition typically affects the big toe but can also impact other joints, including the knees, elbows, and wrists. Uric acid, a by-product of purine metabolism, accumulates in the body due to overproduction or underexcretion by the kidneys, leading to hyperuricemia…
Gout Market Innovations in Pain Management and Treatment
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Gout Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many…
Gout Therapeutics Market Analysis By Drug Class (Nonsteroidal Anti-inflammatory …
Report Summary
The global gout therapeutics market was valued at USD 2.78 Billion in 2021 and is expected to grow at a CAGR of 13.7% during the forecast period 2023-2032.
Gout Therapeutics Market Introduction
The deposition of monosodium crystals (MSU) into the distal joints and peripheral tissues results in gout, an inflammatory arthritic disease. Gout is a typical type of painful inflammatory arthritis. One joint is typically affected at a time (often…
Global Gout Drugs Market Analysis (2020-2025)
Global Info Research offers a latest published report on Gout Drugs Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Gout Drugs Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/reports/371311/gout-drugs
Market…
Gout Therapeutics Market Emerging Trends And Forecast By 2025
Global Gout Therapeutics Market: Snapshot
The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications.
Patients with multiple episodes of severe gout attacks every year or with…
